LE WE PMID CA
Colitis ulcerosa577Colitis ulcerosa

5 Aminosalicylate

Bacteria (Commensal)

Balsalazide

Colitis (BASKET)

Colitis ulcerosa

Golimumab ttTNFalpha

Interleukin24 MDA7

IP10 (Chemokine)

Leukocytapheresis

Moxibustion

Pouch

RAG2

T bet

2000  
1
1992  
2
Drug management of ulcerative colitis.
[1638200] BMJ 305(6844): 35-8 (1992)
2003  
3
Murine models of ulcerative colitis.
[12877549] Arch Pharm Res 26(6): 433-40 (2003)
2010  
4
Moxibustion for ulcerative colitis: a systematic review and meta-analysis.
[20374658] BMC Gastroenterol 10(-): 36 (2010)
2009  
5
Therapeutic strategies for the management of ulcerative colitis.
[18985710] Inflamm Bowel Dis 15(6): 935-50 (2009)
2009  
6
Treatment of choice for acute severe steroid-refractory ulcerative colitis is colectomy.
[19009603] Inflamm Bowel Dis 15(1): 146-9 (2009)
2009  
7
Treatment of choice for acute severe steroid-refractory ulcerative colitis is remicade.
[18942766] Inflamm Bowel Dis 15(1): 143-5 (2009)
2009  
8
How should we treat severe acute steroid-refractory ulcerative colitis?
[18844216] Inflamm Bowel Dis 15(1): 150-1 (2009)
2009  
9
Melatonin and ulcerative colitis: evidence, biological mechanisms, and future research.
[18626968] Inflamm Bowel Dis 15(1): 134-40 (2009)
2009  
10
Treatment of choice for acute severe steroid-refractory ulcerative colitis is cyclosporine.
[18266232] Inflamm Bowel Dis 15(1): 141-2 (2009)
2008  
11
Endoscopic and chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis.
[17973300] Inflamm Bowel Dis 14(2): 259-64 (2008)
2002  
12
Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review.
[12131612] Inflamm Bowel Dis 8(4): 277-86 (2002)
2006  
13
Cellular and molecular immunopathogenesis of ulcerative colitis.
[16549047] Cell Mol Immunol 3(1): 35-40 (2006)
2005  
14
Medical and surgical management of chronic ulcerative colitis.
[15781797] Arch Surg 140(3): 300-10 (2005)
2007  
15
Review article: the management of steroid dependency in ulcerative colitis.
[17767462] Aliment Pharmacol Ther 26(6): 779-94 (2007)
2007  
16
Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis.
[17697199] Aliment Pharmacol Ther 26(5): 653-63 (2007)
2007  
17
MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials.
[17593066] Aliment Pharmacol Ther 26(2): 205-15 (2007)
2007  
18
Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild to moderate distal ulcerative colitis.
[17555418] Aliment Pharmacol Ther 26(1): 21-9 (2007)
2007  
19
Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
[17439506] Aliment Pharmacol Ther 25(9): 1055-60 (2007)
2007  
20
Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis.
[17311598] Aliment Pharmacol Ther 25(6): 657-68 (2007)
2007  
21
Systematic review: Infliximab therapy in ulcerative colitis.
[17229218] Aliment Pharmacol Ther 25(1): 19-37 (2007)
2006  
22
Review article: evolutionary advances in the delivery of aminosalicylates for the treatment of ulcerative colitis.
[16886912] Aliment Pharmacol Ther 24(3): 465-74 (2006)
2006  
23
Systematic review: adherence issues in the treatment of ulcerative colitis.
[16480396] Aliment Pharmacol Ther 23(5): 577-85 (2006)
2005  
24
Review article: how and when to use ciclosporin in ulcerative colitis.
[16268964] Aliment Pharmacol Ther 22(10): 907-16 (2005)
2004  
25
How effective are the usual treatments for ulcerative colitis?
[15233693] Aliment Pharmacol Ther 20(2): 143-9 (2004)
2002  
26
Review article: Immunosuppressants in distal ulcerative colitis.
[11860400] Aliment Pharmacol Ther 16(2): 181-7 (2002)
2001  
27
Review article: balsalazide therapy in ulcerative colitis.
[11563993] Aliment Pharmacol Ther 15(10): 1549-54 (2001)
2009  
28
Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis.
[19392869] Aliment Pharmacol Ther 30(2): 126-37 (2009)
2008  
29
Review article: new drug formulations, chemical entities and therapeutic approaches for the management of ulcerative colitis.
[18627362] Aliment Pharmacol Ther 28(7): 815-29 (2008)
2008  
30
Review article: nitric oxide from dysbiotic bacterial respiration of nitrate in the pathogenesis and as a target for therapy of ulcerative colitis.
[18194497] Aliment Pharmacol Ther 27(7): 531-41 (2008)
2006  
31
Review article: maintenance therapy in patients with ulcerative colitis.
[16939425] Aliment Pharmacol Ther 24 Suppl 1(-): 17-22 (2006)
2006  
32
Review article: induction therapy for patients with active ulcerative colitis.
[16939424] Aliment Pharmacol Ther 24 Suppl 1(-): 10-6 (2006)
2002  
33
Review article: ulcerative colitis--surgical indications and treatment.
[12047256] Aliment Pharmacol Ther 16 Suppl 4(-): 25-8 (2002)
2002  
34
Review article: maintenance of remission in ulcerative colitis.
[12047255] Aliment Pharmacol Ther 16 Suppl 4(-): 21-4 (2002)
2002  
35
Review article: treatment of mild to moderate ulcerative colitis and pouchitis.
[12047254] Aliment Pharmacol Ther 16 Suppl 4(-): 13-9 (2002)
2002  
36
Review article: medical treatment of severe ulcerative colitis.
[12047253] Aliment Pharmacol Ther 16 Suppl 4(-): 7-12 (2002)
2002  
37
Review article: monitoring activity in ulcerative colitis.
[12047252] Aliment Pharmacol Ther 16 Suppl 4(-): 3-6 (2002)
1993  
38
Treatment of ulcerative colitis with 5-aminosalicylic acid.
[8379609] Ann Intern Med 119(8): 858-9 (1993)
1993  
39
Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis.
[8095128] Ann Intern Med 118(7): 540-9 (1993)
1966  
40
2003  
41
Inflammatory bowel disease Part 1: ulcerative colitis--pathophysiology and conventional and alternative treatment options.
[12946238] Altern Med Rev 8(3): 247-83 (2003)
2006  
42
Ulcerative colitis: diagnosis and management.
[16902215] BMJ 333(7563): 340-3 (2006)
2011  
43
Current treatment of ulcerative colitis.
[21912469] World J Gastroenterol 17(27): 3204-12 (2011)
2007  
44
Ileal pouch surgery for ulcerative colitis.
[17659667] World J Gastroenterol 13(24): 3288-300 (2007)
2008  
45
Treatment of severe steroid refractory ulcerative colitis.
[18810767] World J Gastroenterol 14(36): 5508-11 (2008)
2010  
46
Infliximab for the treatment of acute exacerbations of ulcerative colitis.
[20507798] Health Technol Assess 14 Suppl 1(-): 9-15 (2010)
2009  
47
Infliximab for the treatment of ulcerative colitis.
[19846023] Health Technol Assess 13 Suppl 3(-): 7-11 (2009)
2011  
48
Treatment algorithm for moderate to severe ulcerative colitis.
[21706453] Swiss Med Wkly 141(-): w13235 (2011)
2008  
49
Review and clinical perspectives for the use of infliximab in ulcerative colitis.
[18354755] Can J Gastroenterol 22(3): 261-72 (2008)
2011  
50
Role of the interleukin 24 in patients with ulcerative colitis.
[21287675] Inflamm Bowel Dis 17(10): 2209-10 (2011)
2011  
51
Maintaining remission in ulcerative colitis--role of once daily extended-release mesalamine.
[21448448] Drug Des Devel Ther 5(-): 111-6 (2011)
2012  
52
The proximodistal aggravation of colitis depends on substance P released from TRPV1-expressing sensory neurons.
[22080974] J Gastroenterol 47(3): 256-65 (2012)
2008  
53
Infliximab in ulcerative colitis.
[19707369] Biologics 2(3): 379-88 (2008)
2009  
54
T-bet-/- RAG2-/- ulcerative colitis: the role of T-bet as a peacekeeper of host-commensal relationships.
[19666230] Cytokine 48(1-2): 144-7 (2009)
2010  
55
Systematic review: granulocyte/monocyte adsorptive apheresis for ulcerative colitis.
[21050231] Aliment Pharmacol Ther 32(11-12): 1297-306 (2010)
PMC   
56
Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study.
[23461895] Gut 63(3):442-50 (2014)
PMC   
57
Ulcerative colitis and immunoglobulin G4.
[24516698] Gut Liver 8(1):29-34 (2014)
PMC   
58
Golimumab for the treatment of ulcerative colitis.
[24648749] Clin Exp Gastroenterol 7():53-9 (2014)
PMC   
59
Assessing Disease Activity in Patients with Ulcerative Colitis.
[24672411] Gastroenterol Hepatol (N Y) 8(11):751-4 (2012)
PMC   
60
Advances in the treatment of ulcerative colitis.
[24772050] Gastroenterol Hepatol (N Y) 9(12):827-9 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


  • Colitis ulcerosa: Diagnostik und Therapie


  • Search PubMed and many other databases on the combined search terms

    GG: colitis ulcerosa

  • Colitis ulcerosa

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia